Urology 1997: Vol 50 Index

13 Pages·1997·4.8 MB·English

UROLOGY VOLUME 50, JULY TO DECEMBER 1997
Pages Issue Pages Issue
1-162 July 489-658 October
163-318 August 659-830 November
319-488 September 831-1028 December
(6A-1-6A-114) December Supplement
AUTHOR INDEX
Abad, J.1., 978 Barthelemy, Y., 207 Buch, J.P., 438 Coffey, D.S., 800
Abraham, E.H., 199 Bauer, J.J., 192 Buchner, D.A., 79 Cohen, M.S., 657
Abrahamsson, P.-A., 379, Bazinet, M., 704 Buhler, K.R., 567 Constantinidis, C., 754
747 Beechinor, D., 39 Bump, R.C., 6A-15 Contreras, B.A., 229
Abrams, P., 6A-1 Begg, M.D., 73 Busch, C., 562 Coogan, C.L., 957
Acierno, J.S., 999 Bégin, L.R., 994 Bush, I.M., 827 Cooper, C.S., 280
Acker, M., 975 Beneck, D., 456 Buzzeo, B.D., 525 Corey, E., 184, 567
Adams, G., 349 Benedetti, G., 888 Corica, F.A., 427
Adams, M.C., 106 Benken, N., 6A-4 Cadeddu, J.A., 251, 391 Corn, B.W., 385
Adolfsson,J. , 722 Bennett, C.L., 79, 366 Callas, P.W., 655 Costello, L.C., 3
Agarwal, A., 409, 414, 759 Benson, M.C., 73 Campbell, S.C., 25 Cox, J.L., 715
Agha, A., 13 Bergdahl, S., 615 Candas, B., 309, 913 Cox, K., 588
Ahlering, T.E., 418 Bergstralh, E.J., 733 Canning, D.A., 263 Cozzolino, D., 125
Ahlgren, G., 379 Berian, J.M., 978 Cao, L.C., 173 Cozzolino, DJ., 128
Ahlstrand, C., 214 Berlane, K., 100 Caplan, R., 309 Crawford, E.D., 366, 1027
Albert, P., 849 Bernardi, R.J., 292 Capristo, E., 888 Critz, F.A., 481
Alcini, A., 888 Bernier, P.A., 618 Cardozo, L., 6A-85 Cummings, J.M., 292
Alcini, E., 764, 888 Bernstein, M.R., 975 Carlsson, P., 214
Alexander, A., 385 Beurton, D., 207 Carlsson, S., 189 D’Addessi, A., 888
Alexander, A.A., 906 Bhargava, V., 373 Carney, K.J., 449 Dahiya, R., 818
Alexander, R.B., 893 Bibbo, M., 117, 869 Carpenter, C., 863 Dahms, S.E., 818
Alivizatos, G., 754 Bihrle, R., 957 Carretero, P., 31 D’Amico, A.V., 385
Alvarez-Vijande, R., 31 Bite, U., 597 Carroll, P.R., 373 D’Ancona, C.A.L., 593
Ametani, M.S., 142 Blackwood, N.B., 934 Casale, A.J., 796 Darson, M.F., 597
Amling, C.L., 733 Blaivas, J.G., 6A-34 Casodex Combination Study Da Silva Lavoura, N., Jr., 593
Anderson, J.C., 953 Block, C., 1016 Group, 309, 330 Davis, J.W., 121
Andersson, K.-E., 6A-74 Block, N.L., 309, 330 Catalona, W.J., 239, 901 Dawson, L., 1027
Andrawis, R., 438 Blomavist, P., 214 Cease, K., 401 Day, R.S., 999
Andriole, G.L., 901 Bloom, D., 648 Cella, D., 920 DeAntoni, E., 366
Angulo, J.C., 308 Bloom, D.A., 157, 826 Cendron, M., 128 Debré, B., 245
Appell, R.A., 974, 6A-90 Blumenstein, B.A., 49, 349, Chamberlin, D.A., 418 de Bruijn, W.C., 173
Aprikian, A.G., 704 882, 1027 Chan, D.W., 715 Debruyne, F.M.J., 55, 221
Aravantinos, G., 754 Blute, M.C., 833 Chang, G., 100 Decker, R.S., 465
Arda, K., 625 Blute, M.L., 163, 733 Chang, L.S., 235 de Gier, R.P.E., 462
Arfman, E.W., 184 Boevé, E.R., 173 Chartier, E., 207 de Groat, W.C., 6A-36
Arger, P., 385 Boone, T.B., 941 Chassagne, S., 618 Deguchi, T., 826
Arnold, S.J., 479 Borirakchanyavat, S., 373 Chen, C., 913 deKernion, J.B., 341
Artibani, W., 6A-25 Borum, M.L., 443 Chen, K.-K., 235 Delaney, T.F., 199
Asanuma, H., 19 Bose, S., 789 Chen, R.N., 25, 195 de la Rosette, J.J.M.C.H., 55,
Ask, A., 747 Bostwick, D.G., 302, 355, Chen, S.-S., 235 221
Atala, A., 489 427, 679, 733 Chen, W:S., 953 De Lisa, A., 459
Auclair, B., 39 Botega, N.J., 593 Cheng, E.Y., 465, 769 Deliveliotis, C., 754
Aus, G., 615 Boulas,J. , 690 Chevillard, S., 245 De Moraes, C., 593
Bowers, G.W., 63 Chin, D.H., 612 Deng, G., 173
Baba, S., 19 Boyer, M.J., 588 Chiou, R.K., 953 Denstedt, J.D., 875
Babaian, R.J., 66 Boyle, P., 483 Chiu, A.W., 235 Deshon, G.E., Jr., 120
Babayan, R.K., 685 Brading, A.F., 6A-57 Chodak, G., 920 deVries, C.R., 160, 453
Bach, M., 13 Brady, F., 893 Chodak, G.W., 349, 1027 de Vries, J.D.M., 462
Bagley, D.H., 117, 321, 519, Bratt, O., 360 Choyke, P.L., 199 de Water, R., 173
869 Brawer, M.K., 665 Christie, D.W., 483 DeWolf, W.C., 395
Bagli, D.J., 432 Briggman, J.V., 800 Chuaqui, R.F., 302 Dhir, R., 999
Balaji, K.C., 1007 Brock, G.B., 994 Chun, S.S., 875 Dillioglugil, O., 913
Balbay, M.D., 673 Brownstein, K., 385 Chun, T.Y., 727 Diment, M., 39
Bamia, C., 754 Bruce, R.G., 513 Chung, S.-K., 963 Dimopoulos, C., 754
Bandekar, R., 401 Brunelle, S.L., 349 Churchill, B.M., 260, 427 Dimopoulos, M.A., 754
Banerjee, M., 537 Bruning, C.O., III, 395 Cilento, B.G., Jr., 279 Dinney, C.P.N., 673
Baniel,J. ,6 97 Bruskewitz, R.C., 142, 983 Clark, J.Y., 665 Dion, S.B., 994
Barmat, M., 316 Bruzek, D.J., 715 Clayman, R.V., 391, 854 Djavan, B., 986
© 1997, ELseviER SCIENCE INC. 0090-4295/97/$17.00
ALL RIGHTS RESERVED PII S0090-4295(97)00679-1 1028E
Docimo, S.G., 289, 313 Friauf, W.S., 199 Hellstrom, W.J.G., 622 Kay, R., 110, 774
Doi, T., 826 Friedrichs, P., 665 Henderson, M., 349 Keating, M.A., 106
Donohue, J.P., 957 Fry, C.H., 6A-70 Hensle, T.W., 282 Keetch, D.W., 901
Dorey, FJ., 341 Fuchs, E.F., 612 Herschman, J.D., 239 Khadra, M., 690
Drummond, M.F., 6A-108 Fuchs, G.J., 138 Herts, B., 25 Khonsari, F., 418
Duckett, J.W., 263 Furr, 3., 309 Heston, W., 840 Khoudary, K.P., 395
Duray, P.H., 302 Fuselier, H.A., Jr., 337 Hill, T.M., 710 Khoury, A.E., 260, 432
Durrani, O., 66 Hinman, F., Jr., 486 Kim, J.H., 229
Galloway, N., 630 Hodges, F., 161 Kim, Y.H., 941
Edelstein, R.A., 826 Garlovsky, 1.S., 827 Holmberg, L., 562 Kirsch, A.J., 263
Egevad, L., 562 Garnick, M.B., 366 Holmes, N.M., 279 Kleiner, D.E., 295
Eggersmann, C., 6A-4 Gearhart, J.P., 285, 967 Holtgrewe, H.L., 214 Klotz, L.H., 831
Einarson, T.R., 39 Gebrosky, N.P., 863 Hosseinian, A.A., 446 Knight, S.J., 366
Einhorn, L.H., 957 Geib, K.S., 508 Houlgatte, A., 207 Kobelt, G., 6A-100
Eisinger, D., 690 Geirsson, G., 6A-34 Hoven, A.D., 513 Koenig, F., 778
Ekbom, A., 214 Gemalmaz, H., 625 Howard, P., 263 Kogan, S.J., 456
Elashry, O.M., 391 Gentle, D.L., 508 Hsu, I.-C., 73 Kojima, M., 548
Elbadawi, A., 6A-71 Gerber, G.S., 229 Hudson, M.A., 349 Kok, D.J., 173
Elhilali, M.M., 704 Getzenberg, R.H., 999 Hugosson,J. , 615 Kolligian, M.E., 456
Ellis, W.J., 184, 349, 573, Gheiler, E.L., 580 Hunt, M., 87 Kolvenbag, G.J.C.M., 309,
882 Ghossein, R.A., 100 Hurley, K., 295 330
Elzinga, L.W., 606 Gill, H.S., 63 Husmann, D.A., 427, +79 Konety, B.R., 604, 999
Emerson, L., 495 Ginsberg, D.A., 273 Hussain, S., 685 Konowalchuk, T.W., 63
Emery, R.T., 780 Glatstein, E., 199 Hwang, P., 39 Kostakopoulos, A., 754
Emmert-Buck, M.R., 302 Glazer, A.A., 812 HYCAT Investigator Group, Koukol, S., 863
Enfield, D.L., 882 Glazier, D.B., 972 556 Koul, H., 1007
Englert, C.R., 302 Gnarra, J.R., 295 Hyslop, T., 385 Kral, J.G., 472
Engstrand, L., 189 Goldinger, M., 436 Kramer, S.A., 597
Ennis, R.D., 73 Goldstein, M., 257 Ikemoto, I., 759 Krarup, T., 13
Epstein, J.I., 251, 800 Gomella, L., 385 Ingenito, A.C., 73 Krishnamurthi, V., 132
Esper, P., 920 Gomella, L.G., 906 Inman, S.R., 812 Kristoffersson, U., 360
Esper, P:S., 401 Gonzales, E.T., 963 Irby, P.B., 192 Krithivas, K., 100
Evans, C.L., 715 Gormley, G., 13 Isen, J., 135 Kumar, A., 710
Gould, A.L., 483 Ishak, L.M., 027 Kupelian, P., 481
Fair, W.R., 840 Grasso, M., III, 601 Ismail, M., 906
Falkmer, U., 379 Grauer, L.S., 710 Issa, M.M., 986
Fall, M., 6A-34 Greenburg, R., 513 Labrie, C., 913
Fanasca, A., 888 Griffiths, D.J., 6A-53 Jackman, S.V., 609 Labrie, F., 309, 479, 913,
Farrow, G.M., 679 Grignon, D., 537 Jackson, S., 6A-18 1028
Feitz, W.F J., 462 Grygiel,J ., 588 Jarow, J.P., 659 Lagerkvist, M., 13
Fenlon, H.M., 685 Gulino, G., 764 Jarowenko, M.V., 349 Lakshmanan, Y., 285
Ferguson, K., 1016 Gunes, Z.E., 625 Jarrett, T.W., 508 Lamm, D.L., 349, 436, 863
Ferral, H., 113 Gutiérrez-Aceves, J., 138 Jayanthi, V.R., 260 Landau, E.H., 260
Ferzli, G., 849 Jeffs, R.D., 289, 967 Lang, S., 465
Fielding, J.R., 792 Haab, F., 585 Jerauld, R.S., 513 Lange, P.H., 573
Finasteride PSA Study Haas, C., 1016 Jimenez-CruJz.,F. , 529 Langlotz, C., 385
Group, 13 Hagen, L., 700 Johansen, T., 13 Lapco, P.E., 999
Findlay, M.P.N., 588 Haggman, M.J., 643 Johansson, J.-E., 214 Larsen, L.D., 418
Finger, MJ., 192 Haitel, A., 781 Johnson, C.S., 999 Lashley, D.B., 612
Finlay, J.A., 715 Hall, R., 49 Johnson, R.D., 349 Laxmanan, S., 1007
Firlit, C., 160 Halpern, EJ., 519 Johnston, B., 495 Leach, G.E., 63, 585
Firlit, C.F., 465, 769 Hampel, C., 6A-4 Jones, J.A., 784 Lee, C., 465
Fischler, D.F., 25 Hampel, N., 1016 Joyner, B.D., 489 Lehman, T.H., 606
Fivush, B., 289 Hanks, G.E., 87 Leibman, B.D., 93
Flam, T.A., 245 Hanlon, A.L., 87 Kabalin, J.N., 63, 827 Leidich, R.B., 784
Fleiss, P.M., 161 Hanno, P.M., 858 Kaefer, M., 106 Leiva, O., 529
Fleming, R.A., 446 Hansen, B.J., 483 Kalloo, N.B., 967 Lepor, H., 727
Fleshner, N.E., 840 Harris, J.M., 44 Kane, C.J., 279 Leung, W., 122
Flores, N., 529 Harrison, R.H. III, 317 Kantoff, P.W., 100 Levin, H.S., 25
Fogarty,J. , 1016 Harshaw, D.W., 263 Kaplan, G.W., 453 Levin, R.M., 6A-87
Fontaine, E., 207 Hawtrey, C.E., 280 Kaplan, W.E., 465, 769 Levy, D.A., 673
Foster, R.S., 957 Heaney, J.A., 125 Karakiewicz, P.I., 704 Levy, J.B., 597
Fowler, J.E., Jr., 483 Heaton, J.P.W., 122, 495 Karram, M.M., 934 Leyh,J. , 49
Fralick, R., 974 Hedlund, P.-O., 722 Kastriotis, I., 754 Liberman, S.N., 519
Frankel,J ., 657 Heffner, D.K., 485 Kattan, M.W., 93, 941 Lieskovsky, G., 740
Frankel, S., 319 Heidenberg, H.B., 192 Kavaler, E., 282 Light, B.W., 999
Franklin, R.B., 3 Heinz, G., 986 Kavoussi, L.R., 195, 391, 854 Lin, ATL... 235
Freedman, G.M., 87 Heinz-Peer, G., 781 Kawabe, K., 6A-98 Lindholm, K., 379
Freiha, F.S., 485 Heisey, D.M., 525, 700 Kawada, Y., 826 Lindstrom, S., 6A-34
1028F UROLOGY 50 (6), 1997
Linehan, W.M., 199, 295, Mitra, S., 1007 Pages, F., 245 Rittenhouse, H.G., 567, 573,
302 Mitterdorfer, A., 690 Pak, C.Y.C., 504 710, 715
Liotta, L.A., 302 Miyajima, A., 19 Palmer, L.S., 769 Robertson, A., 55
Litzky, G.M., 160 Miyakawa, A., 19 Pamplona, M., 529 Rodriguez, A., 31
Loeffler, J.A., 685 Mo, F., 920 Pannek,J. , 715 Rodriguez-Rubio, F.1., 978
Loggie, B.W., 446 Monga, M., 113, 622 Panopoulos, C., 754 Roehrborn, C.G., 483, 556
Lopez-Beltran, A., 427 Montie, J.E., 308, 580 Pantazopoulos, D., 754 Rogenes, V.J., 44
Loughlin, K.R., 391, 759, Moon, T.D., 543, 700 Park, C., 341 Rogers,J. , 588, 690
792 Moore, R.G., 195, 391 Parra, R.O., 292 Rosai,J. , 100
Lowe, B.A., 612 Morales, A., 122, 495 Partin, A.W., 251, 715, 800 Rosier, P.F.W.M., 55
Lowe, F.C., 593, 929 Morcos, E., 189 Parulkar, B.G., 135 Rosinsky, D.E., 953
Lubensky, I.A., 295 Morey, A.F., 423 Patel, A., 138 Ross,J. , 774
Luderer, A.A., 655 Morgentaler, A., 395 Patel, J.V., 349 Ross, J.H., 110
Lue, T.F., 818 Morrison, J.F.B., 6A-55 Patriarca, G., 764 Roth, B.J., 957
Lundberg, J.O.N., 189 Moses, F.M., 192 Patterson, A.L., 309, 330 Roth, D.R., 963
Lundgren, R., 360 Mostafavi, M.R., 601 Paulis, M., 459 Rovner, E.S., 273
Lundin, S.-E., 615 Mostwin, J.L., 6A-68 Pearsall, C.P., 643 Rowland, R.G., 957
Luo, S., 913 Motta,J. , 432 Peehl, D.M., 150 Roy,J. , 13
Movsas, B., 87 Peerzada,J. , 125 Ruiz, H.E., 444
Macairan, M.L., 341 Mulhall, J.P., 438 Perez, M.A., 740 Rukstalis, D.B., 229
Macarak, E.J., 263 Multi Center Study Group, Persson, U., 747 Russi, M.F., 316
Macchia, R.J., 472 882 Petersen, R.O., 906 Rutter, P.W., 513
MacDiarmid, S.A., 780 Munch, L.C., 513 Peterson, A.C., 444
MacLennan, G.T., 679 Murai, M., 19 Pfalzgraf, R.D., 349 Saboorian, M.H., 618
Macoska, J.A., 643 Murchison, H.A., 349 Piechota, H.J., 818 Saedi, M.S., 710
Maizels, M., 465, 769 Mydlo, J.H., 472 Pienta, K.J., 401, 920 Saidi, J.A., 789
Malhotra, R.K., 1007 Pinover, W.H., 87 Sakamoto, H., 636
Malkowicz, S.B., 385, 975 Naik, H., 401 Pisansky, T.M., 87 Sakr, W., 537
Malmberg, I., 747 Nangia, A.K., 999 Pisters, L.L., 673 Sala, X., 31
Malone-Lee,J. , 6A-86 Naslund, M.J., 167 Polak,J. , 1016 Sall, M., 142, 983
Manepalli, A., 292 Nasrallah, P., 774 Ponniah, S., 893 Salle, J.P., 432
Maralani, S., 537 Naya, Y., 548 Pontes, J.E., 537, 580 Saltzman, B., 601
Maramag, C., 1007 Neal, D.E., 55 Poppas, D.P., 160 Sand, P.K., 934
Marberger, M., 781, 986 Nesbitt, J.C., 673 Porru, D., 459 Santos, J.K., 593
Marks, L.S., 341 Netto, N.R., Jr., 593 Porter, W.H., 513 Saporta, F., 245
Martel, C., 913 Newman, R.C., 657 Porterfield, H.A., 366 Saray, A., 625
Martin, E., 245 Newschaffer, C., 906 Postoak, D., 113 Sarosdy, M.F., 309, 330, 349
Martin, S., 727 Ng, W.T., 313 Pozzatti, R., 295 Sarver, R.G., 656
Martin, S.K., 733 Nguyen, A., 784 Prasad, P.V., 601 Sasso, F., 764
Martinez-Lasierra, M., 529 Ni, Z., 1016 Preminger, G.M., 504 Sato, C., 636
Mason, C., 337 Nill, T., 63 Presti, J.C., Jr., 373 Sawezuk, I.S., 789
Matamoros, A., Jr., 953 Nishizawa, O., 6A-23 Preston, D.M., 192 Saxon, R.R., 612
Mathews, R., 289 Norberg, M., 562 Pulliam, J.P., 606 Scardino, P.T., 93
Mattiasson, A., 6A-111 Norlén, B.J., 562 Pycha, A., 781 Scarpa, R.M., 459
Norton, C., 6A-23
Maussier, M.L., 888 Schaeffer, A., 980
Norton, P.A., 6A-97
Mazeman, E., 49 SchellengeJr.,J. , 330
McAninch, J.W., 423 Noteboom, J.L., 573 Rabago, G., 978 Schellhammer, P.F., 121,
McCue, P.A., 869 Novick, A.C., 25, 132, 812, Raboy, A., 849 309, 330, 349, 449, 827
McDougal, W.S., 648 863 Racioppi, M., 888 Schenkman, E., 436
McGovern, F.J., 778 Nseyo, U.O., 863 Rajfer,J. ,2 77, 809 Scher, H.I., 100
Mclver, B.J., 44 Nucera, E., 764 Ratliff, T.L., 901 Schervish, E.W., 349
McLaughlin, K.P., 106 Nunes, L., 818 Raz, S., 273 Schiavino, D., 764
McLorie, G., 432 Nyguen, T., 295 Razmjouei, K., 1016 Schiff, P.B., 73
McLorie, G.A., 260 Razvi, H.A., 875 Schlegel, P.N., 656
Melchior, S.W., 184 Ochiai, A., 548 Reddy, P., 1007 Schneck, F.X., 604
Menéndez, V., 31 Oesterling, J.E., 1, 13, 556 Redman, B.G., 401 Schoenberg, M., 609
Meng, M.V., 423 Okunieff, P.G., 199 Reich, J.D., 858 Schréder, F.H., 173
Menon, M., 1007 Olson, P.J., 556 Reisinger, S., 385 Schuessler, W.W., 854
Merlin, S.L., 994 Olsson, H., 360 Reiter, W.J., 781 Schulam, P., 391
Messing, E.M., 525 Optenberg, S.A., 665 Renshaw, A., 792 Schulam, P.G., 609, 854
Meyer,J. , 25, 800 Oreper, A., 800 Resnick, M.1., 504 Schulman, C.C., 986
Meyerowitz, B.E., 740 Oswin, M.M., 184 Resnick, N.M., 6A-109 Schultheiss, T.E., 87
Micali, S., 195 Oyasu, R., 980 Reynolds, B., 740 Seale-Hawkins, C., 93
Mikolajczyk, S.D., 710 Ozdemir, B.H., 625 Rhodes, P.R., 142 Seay, T.M., 833
Milani, A., 764 Ozdemir, O.G., 625 Richardson, D.A., 934 Seftel, A.D., 1016
Millar, L.S., 710 Richie, J.P., 838 Seiden, M., 100
Miller, K.L., 934 Pacelli, A., 355, 427 Riehmann, M., 142 Sensibar, J.A., 465
Mingrone, G., 888 Packer, M.G., 972 Rink, R.C., 106 Seo, R., 980
Minimo, C., 869 Padley, RJ., 556 Rioja-Sanz, L.A., 529 Seyam, R.M., 994
UROLOGY 50 (6), 1997
Shafik, A., 949 Steele, G.S., 792 Trump, D.L., 999 Wein, A.J., 385, 975, 6A-1,
Shandera, K., 120 Steers, W.D., 6A-54 Tse, V., 690 6A-114
Shariat, S., 986 Stein, C.R., 665 Tu, L.M., 994 Weinhold, D., 6A-4
Sharifi, R., 309, 330 Steinberg, G.D., 229 Tuteja, A.K., 606 Weitzberg, E., 189
Sharma, R.K., 409, 414 Steineck, G., 722 Tuttle, J.P., 934 Werner-Wasik, M., 385
Sharp, L., 366 Stetler-Stevenson, W.G., 295 Werthman, P., 277, 809
Shawker, T.H., 199 Stokes, S., 438 Uchida, A., 19 West, D.A., 292
Sheinfeld,J. , 349 Stoller, M.L., 508 Ukimura, O., 66, 548 Wheeler, T.M., 93
Shinohara, K., 373 Stone, N.N., 366 Ullman, M., 79 White, R.D., 349
Shown, T., 13 Stowe, N.T., 812 Unda, M., 529 Whittington, R., 385
Shurin, Z., 999 Straub, M., 784 Usai, E., 459 Wienhold, D., 6A-4
Siegel, S.W., 934 Strawderman, M., 401 Uznis, G., 648 Wiesbrock, S., 800
Siegelman, E.S., 975 Strup, S.E., 302 Wijkstra, H., 221
Sigman, M., 659 Subong, E.N.P., 715, 800 Valenza, V., 888 Wiklund, N.P., 189
Silverman, D.E., 986 Sullivan, K., 519 Van Howe, R.S., 315 Williams, W.H., 481
Simard,J. , 309 Sun, M., 100 Van Savage, J., 432 Wills, M.L., 285
Simon, J.M., 113 Susani, M., 986 van Waalwijk van Doorn, Winfield, H.N., 391
Singal, R.K., 875 Sutherland, R.W., 963 E.S.C., 6A-33 Witjes, W.P.J., 55, 221
Singh, S.M., 309, 913 Swanson, D.A., 673 Vargas, M.P., 199 Wobig, R.K., 953
Singla, A., 630 Szaro, R., 800 Vasavada, S., 774 Wojno, K,J., 643
Sinner, M., 920 Vaziri, N.D., 1016 Wolf, S., 784
Skinner, D.G., 740 Takahashi, Y., 826 Veech, R.L., 784 Wolfert, R.L., 567, 573, 710
Skinner, E.C., 740 Takenaka, I., 636 Venner, P.M., 330 Wong, Y.T., 313
Slaton, J.W., 673 Tanagho, E.A., 818 Venzon, D., 295 Wood, A.F., 508
Slezak, J.M., 733 Tarry, W.F., 436 Vera-Donoso, C.D., 529 Wood, D.P., Jr., 537, 580
Smith, D.C., 401 Tattersall, M.H.N., 588 Vessella, R.L., 184, 567, 573 Wood, J.C., 622
Smith, D.N., 974 Tawfiek, E., 117 Vieillefond, A., 245 Wright, EJ., 257
Smith, D.P., 160 Tawfiek, E.R., 321, 869 Vishna, T., 697
Smith, D.S., 239 Taylor, RJ., 953 Vocke, C.D., 302
Yang, M., 826
Smith, E.R., Jr., 957 Teichman, J.M.H., 44 Vogelzang, N.J., 309, 330,
Young, C.Y.-F., 184
Smith, J.A., Jr., 529 Tennvall,J. , 747 401
Young, G.P.H., 257
Smith, P.D., 199 Terris, M.K., 150
Young, R.H., 427
Snyder, H.M., 263 Thibault, G., 120 Waldstreicher,J. , 13
Snyder, O., 391 Thiel, R., 655 Walker, J.R., 796
Socher, S.A., 316 Thiounn, N., 245 Walsh, P.C., 251, 1028 Zagaja, G.P., 229
Soderdahl, D.W., 444 Thoelke, K.R., 349 Walther, M.M., 199, 295, Zderic, $.A., 263
Solé, M., 31 Thomas, G.F., 199 485 Zerbib, M., 245
Soloway, M.S., 309, 330, Thomas, R., 113 Wang, R.-Z., 1016 Zervas, A., 754
349, 685 Thompson, I.M., 665 Wang, TJ., 567 Zhang, X.-H., 636
Sparén, P., 562 Thuroff, J.W., 6A-4 Wang, Y., 409, 414 Zhang, Z.-F., 100
Spence, H., 648 Tindall, D.J., 184 Ward, J.F., 508 Zhuang, Z., 302
Staiman, V.R., 929 Toke, A., 373 Watanabe, H., 548 Zimmern, P.E., 618
Stanley, D.E., 655 TomaszewskiJ.,E. , 975 Watanabe, M., 548 Zincke, H., 733, 833
Staskin, D.R., 934 Trifilio, D., 135 Watson, R.A., 192 Zlotta, A.R., 986
UROLOGY 50 (6), 1997
SUBJECT INDEX renal. See Renal biopsy
systematic sextant, prediction of extracapsular extension
at radical prostatectomy, 373
(Page numbers in the Supplement to the December issue are ultrasound-guided, sextant protocol, prostate cancer
preceded by a “6A-”.) underestimation, 562
ureteroscopic, 117
Biopsy needle, Turner, for seminal vesicle aspiration, 277
Bladder
Acellular matrix graft, ureteral wall components
external urethral sphincter contraction, 949
regeneration, rat, free ureteral replacement, 818 overactive
Acidosis, renal tubular, 279
definition, 6A-4
Adenocarcinoma, prostate
drug treatment, 6A-74
growth and metastasis, vitamin D, 999
future management, 6A-111
lymph node positive, radical prostatectomy, early
idiopathic, 6A-25
adjuvant hormonal therapy, 833
neurologic basis, 6A-36, 6A-57
Adenoma, nephrogenic, bladder, renal transplantation, 690
symptoms and quality of life, 6A-18
Adipose tissue, fibroblast growth factor, prostate cancer and,
tolterodine treatment, 6A-90
att
thin-section helical computed tomography, virtual reality
Adrenal insufficiency from bilateral adrenal hemorrhage
imaging, 685
after total knee replacement surgery, 125
unstable, 6A-1
Adrenalectomy, retroperitoneal, posterior lumbar approach
Bladder calculi, large, holmium:yttrium-garnet laser
for, assessment of surgical efficacy, 19
cystolithotripsy of, 44
African-American participation in prostate cancer screening
Bladder cancer
(letter), 483
botryoid rhabdomyosarcoma, 604
Allelic loss of 8p sequences, intraepithelial neoplasia and
comparison of Bard BTA test with voided urine and
carcinoma, 643
bladder wash cytology in management and diagnosis
Allograft, renal, nephron-sparing surgery, 132
of, 49
Alprostadil, MUSE therapy, 809
female, urethral involvement, 537
Androgen deprivation, delayed, stage D1 prostate cancer
nephrogenic adenoma, renal transplantation, 690
(editorial), 838
renal transplant recipients, 525
Anesthesia, local, outpatient percutaneous bladder neck
transitional cell carcinoma. See Transitional cell
suspension, 585
carcinoma
Angiography, transjugular transhepatic, bleeding ileal
Bladder cancer, recurrent
conduit stromal varices, 612
BTA TRAK assay voided urine cytology, BARD BTA test,
Angiomyolipoma, progressive, inferior vena cava tumor
882
thrombus, 975
detection using BTA stat test, 349
Angiotensin II, regulation of bladder smooth muscle growth
superficial, immunoprophylaxis, bacille Calmette-Guérin,
and function, 465
interferon-alpha, 529
Antisense oligonucleotide, c-myc, prostate cancer, 1007
Bladder cancer detection, fluorescence, 778
Anuria, obstructive, and dermatomyositis, 135
Bladder cancer risk, intestinal metaplasia and, 427
Assisted reproduction, cost-effectiveness analysis (letter),
Bladder neck suspension
656
laparoscopic, obesity (letter), 657
Ataxia-telangiectasia, metastatic dysgerminoma and,
percutaneous, outpatient, local anesthesia, 585
presenting as urinary incontinence, 453
Bladder outlet obstruction
circadian rhythm in urinary flow values in, 221
elderly men, lower urinary tract symptoms stratified
Bacille Calmette-Guérin, recurrent superficial bladder cancer according to grade of, urodynamic and clinical effects
immunoprophylaxis, 529 of noninvasive and minimally invasive treatments, 55
Bacteriuria, treatment, 189 female, collagen injections, 618
Balloon-wire retrieval of migrated stent (letter), 160 neonatal, captopril inhibition of, 465
Bard BTA test Bladder pseudotumor, inguinal herniorrhaphy, 609
BTA TRAK assay comparison to, recurrent bladder Bladder reconstruction, ileocecal and ileal, vitamin B,, and
tumors, 882 folic acid plasma levels, 888
voided urine and bladder wash cytology comparison, in Bladder replacement, ileal reservoir (letter), 308
diagnosis and management of bladder cancer, 49 Bladder tissue, preservation in different solutions for varying
BTA stat test, recurrent bladder detection using, 349 times, 142
Benign prostatic hyperplasia. See Prostatic hyperplasia, Bladder tumors, inflammatory (pseudosarcomatous)
benign myofibroblastic, 285
Bicalutamide Bladder volume, rapid determination, three-dimensional
compared with flutamide, advanced prostatic carcinoma, ultrasound device, 341
330 Blastomycosis, epididymis and prostate, 980
fulminant hepatic failure (letter), 827, 1027 Blood donation, autologous, preoperative, versus
Biological response modifiers, intralesional administration, preoperative recombinant human erythropoietin
localized cancer of prostate treatment, 495 injection, radical retropubic prostatectomy, 727
Biopsy Bowel segment use for lower urinary tract reconstruction,
prostate. See Prostate biopsy pediatric, long-term nutritional consequences, 967
© 1997, ELseEviER SCIENCE INC. 0090-4295/97/$17.00
ALL RIGHTS RESERVED PII S0090-4295(97)00679-1 10281
Breast, supernumerary, urologic presentation of, 122 Detrusor instability
BTA TRAK assay, clinical evaluation, comparison to voided diagnosis, 6A-25
urine cytology, Bard BTA test, recurrent bladder neurologic control, 6A-57
tumors, 882 DHEA. See Dehydroepiandrosterone
Diabetes, advanced glycation end products, penis, diabetes,
nitric oxide synthase, 1016
Disinfection, high level, liquid sterilization versus, in
Cabot, Hugh, 1872-1945, 648
urologic office, 337
Calciphylaxis, penile, 622 DNA
Calculi computed contact, upper urinary tract transitional cell
bladder. See Bladder calculi carcinoma grading, 869
ethnic and geographic diversity, 504 cytometric proliferation improvement in accuracy of DNA
prostatic urethra. See Prostatic urethral calculi ploidy index as prognosticating tool in carcinoma of
renal. See Renal calculi prostate, 379
Captopril, inhibition of obstructive changes in neonatal Doppler ultrasound, color
bladder, 465 prostate cancer biological behavior, disease-free survival,
Casodex 906
daily dosing, maximal antiandrogenic activity, 913 varicocele, compared with physical examination, 953
estimated potency of (letter), 309 Double-blind studies, 319
Castration plus flutamide, in previously untreated prostate Doxazosin, in men with lower urinary tract symptoms, 229
cancer (letter), 479 Drug therapy, overactive bladder, 6A-74
Catheter, indwelling, urologic complications in male Dysgerminoma, metastatic, ataxia-telangiectasia and,
patients with spinal cord injury and, 418 presenting as urinary incontinence, 453
Chemotherapy, testicular cancer, retroperitoneal lymph
node dissection, 957
Children. See Pediatric urology Economics, urge incontinence, 6A-100
Circle area ratio, presumed, correlation with infravesical Ejaculation, serum total and free prostate-specific antigen
obstruction, in men with lower urinary tract concentrations, 239
symptoms, 548 Elderly men, lower urinary tract symptoms stratified
Circumcision in infancy (letter), 161, 315 according to grade of urinary tract obstruction,
Citrate metabolism, of normal and malignant prostate noninvasive and minimally invasive treatments, 55
epithelial cells, 3 Electrical stimulation, pelvic floor, urge and mixed urinary
c-myc antisense oligonucleotide, prostate cancer, 1007 incontinence, women, 934
Colic. See Renal colic Electrosurgical treatments, prostate, energy utilization
Collagen injection patterns, 138
female bladder outlet obstruction, 618 Electrovaporization, prostate, laser prostatectomy versus
transurethral, urodynamic results and urethral coaptation, (letter), 828
941 Embolization, bleeding ileal conduit stromal varices, 612
Collagen mass in prostatic bed, radical retropubic Endocrine evaluation, infertile men, 659
prostatectomy, 121 Endoscopic substances, treatment of vesicoureteral reflux,
Collecting duct carcinoma, kidney, 673 489
Computed tomography Endoscopy, extraperitoneal radical retropubic
spiral, staghorn calculi, 519 prostatectomy, 849
thin-section, helical, bladder, virtual reality imaging, 685 Endoureterotomy, holmium:yttrium laser, ureteral stricture,
Conduits, jejunal, twenty-year experience, 207 875
Cost-effectiveness analysis, assisted reproduction (letter), Energy utilization patterns, different transurethral
656 electrosurgical treatments of the prostate, 138
Cryopreservation Enuresis (letter), +79
effect on semen quality in patients with cancer, lipid Epididymis, blastomycosis, 980
peroxidation and, 414 Epithelial cells, prostate, citrate metabolism, 3
sperm membrane damage related to, 409 Erectile aids, radical prostatectomy, quality of life and
Cryotherapy, prostate cancer, prostatic urethral stone sexuality, 740
formation, 615 Erectile dysfunction, patient attitudes, prostate cancer
Cystectomy, radical, separated pyelocutaneous diversion treatment, 704
after, for transitional cell carcinoma, 449 Erection, prolonged, newborn, 796
Cystic pyeloureteritis, radiologic aspects and differential Erythropoietin, human, preoperative recombinant injection
diagnosis, 31 versus preoperative autologous blood donation,
Cystic renal disease (letter), 485 radical retropubic prostatectomy, 727
Cystitis, interstitial, pentosan polysulfate, 39 Estramustine, oral, and oral etoposide, hormone-refractory
Cystolithotripsy, holmium:yttrium-garnet laser, large prostate cancer, 401, 754
bladder calculi, 44 Ethnic diversity, stone disease, 504
Cystoprostatectomy, salvage, recurrent prostate cancer, Etoposide, oral, oral estramustine and, hormone refractory
orthotopic urinary diversion, 580 prostate cancer, 401, 754
Female
Decision-making tool, risk of prostate cancer, 665 bladder cancer, urethral involvement, 537
Dehydroepiandrosterone (DHEA), advanced prostate cancer, bladder outlet obstruction, collagen injection, 618
784 Fibroblast growth factor, prostate and adipose tissue,
Dermatomyositis, and obstructive anuria, 135 differences in, 472
10285 UROLOGY 50 (6), 1997
Filiforms, short, working with (letter), 486 Human papillomavirus
Finasteride intraurethral infection, subclinical, treatment, interferon
free prostate-specific antigen, 901 alfa-2b (letter), 317
prostate-specific cancer biological variability and marker polymerase chain reaction in prostate tissue, primer set
for prostate cancer, 13 utilized, 150
Fine needle aspiration, small, solid renal masses, prospective Hyaluronidase, paraphimosis reduction with (letter), 160
evaluation, accuracy and morbidity, 25 Hypospadias repair
Fistula, nephrobronchial and nephrocolonic, complicating de-epithelialized iocal skin flap, tubularization of incised
xanthogranulomatous pyelonephritis, 443 urethral plate, 110
Flap. See Skin flap sutureless, skin flap closure by dermal laser soldering, 263
urethral wall dissection, 462
Fluorescence, bladder cancer detection, 778
5-Fluorouracil, renal cell carcinoma treatment, 863
Flutamide
compared with bicalutamide, advanced prostatic Ileal reservoir, bladder replacement (letter), 308
carcinoma, 330 Immune response, Peyronie’s disease, 764
Immunohistochemical characterization of monoclonal
daily dosing, maximal antiandrogenic activity, 913
antibody (PRO:4-216) human prostate cancer
plus castration, previously untreated prostate cancer
nuclear matrix proteins, 800
(letter), 479
Incontinence, urinary
Folic acid, plasma levels, ileocecal and ileal neobladder
artificial sphincter, recurrence, 972
reconstruction, 888
ataxia-telangiectasia and metastatic dysgerminoma and,
Fossa navicularis, transitional cell carcinoma, 792
453
Free-radical scavengers, testicular damage prevention, 759
definitions, 6A-4
urge, outcome measurement and economic
considerations, 6A-100
Gastric segment, lower urinary tract reconstruction, 630 urge and mixed, pelvic floor electrical stimulation, 934
Genetic alterations, allelic loss of 8p sequences, prostatic Indinavir sulfate-induced urolithiasis, 508, 513
intraepithelial neoplasia and carcinoma, 643 Infertility, male, endocrine evaluation, 659
Infravesical obstruction, presumed circle area ratio
Genetic testing, sons of men with prostate cancer, 360
correlation, men with lower urinary tract symptoms,
Genitourinary malignancies, renal transplantation patient,
548
12
Interferon-alpha, recurrent superficial bladder cancer
Geographic diversity, stone disease, 504
immunoprophylaxis, 529
Germ cell tumor, testicular, nonseminomatous,
Interferon-alpha-2b
orchiectomy, surveillance, 588
renal cell carcinoma treatment, 863
Glycation end products, penis, diabetes, nitric oxide
subclinical intraurethral human papilloma virus infection
synthase, 1016 treatment (letter), 317
Glycosaminoglycans, urolithiasis treatment, 173 Intestinal metaplasia, bladder cancer risk, 427
Graft, skin, tubular, ureteral reconstruction, omentum as Ischemia, warm, renal transplantation, prevention with
carrier, 625 polyurethane bag, 436
Guaiac conversion, stool, extracorporeal shock wave
lithotripsy, 192
Gynecomastia, drug-induced, tamoxifen, 929 Kallikrein, human
glandular
anti-prostate-specific antigen monoclonal antibodies
Hemangioendothelioma, intrascrotal, in infancy, 456 cross-reactivity with, 567
reverse transcriptase-polymer chain reaction,
Hematoma
circulating prostate cells, 184
renal, bilateral, following extracorporeal shock wave
2, molecular forms, early detection and staging of prostate
lithotripsy, anuric renal failure, 606
cancer, 715
subcapsular and perirenal, spontaneous nontraumatic
Kidney. See also Renal cell carcinoma
kidney rupture, chronic hemodialysis, 781
rupture, spontaneous nontraumatic, subcapsular and
Hemodialysis, chronic, spontaneous nontraumatic kidney
perirenal hematoma, chronic hemodialysis, 781
rupture, subcapsular and perirenal hematoma, 781
ureteropelvic junction obstructed, magnetic resonance
Hemorrhage, bilateral adrenal, total knee replacement imaging, 601
surgery, adrenal insufficiency, 125 Knee replacement surgery, total, bilateral adrenal
Hepatic failure, fulminant, bicalutamide (letter), 827 hemorrhage after, adrenal insufficiency from, 125
HER-2 alterations, renal cell carcinoma, 636 Kock pouch, afferent limb, obstruction of, metabolic
Hernia sac, indirect, torsion, scrotal swelling in children, complications secondary to, 289
432
Herniorrhaphy, inguinal, bladder pseudotumor, 609
Hippocrates, and urology, first surgical subspecialty, 157 Laparoscopic surgery
Holmium:yttrium laser endoureterotomy, ureteral stricture, bladder neck suspension, obesity (letter), 657
875 orchidopexy (letter), 313
Holmium:yttrium-garnet laser cystolithotripsy, of large pelvic lymph node dissection, natural history of D1 (T1-3,
bladder calculi, 44 N1-3, MO) prostate cancer, 391
Hormonal therapy, early adjuvant, radical prostatectomy, radical prostatectomy, 854
lymph node positive adenocarcinoma of prostate Laser cystolithotripsy, holmium:yttrium-garnet laser, large
(editorial), 833 bladder calculi, 44
UROLOGY 50 (6), 1997 1028K
Laser endoureterotomy, holmium:yttrium, ureteral stricture, Obesity
875 laparoscopic bladder neck suspension (letter), 657
Laser prostatectomy prostate cancer, 472
versus electrovaporization of prostate (letter), 828 retroperitoneoscopic renal biopsy, 195
neodymium:yttrium-aluminum-garnet, prospective Omentum, as carrier, ureteral reconstruction with tubular
multicenter Prolase II clinical trial of, 63 skin graft, 625
Laser soldering, dermal, skin flap closure by, for sutureless Orchidopexy, laparoscopic (letter), 313
hypospadias repair, 263 Orchiectomy, nonseminomatous testicular germ cell tumor,
Lipid peroxidation surveillance after, 588
effect of sperm concentration on, 409 Outpatient surgery, percutaneous bladder neck suspension,
effect on cryopreserved semen quality in patients with local anesthesia, 585
cancer, +14
Lithotripsy, shock wave, extracorporeal
renal hematoma following, anuric renal failure, 606
p»3
stool guaiac conversion following, 192
alterations, renal cell carcinoma, 636
Lovastatin, renal microcirculatory effects, reduced renal
expression, upper urinary tract transitional cell carcinoma
mass, 812
grading, 869
Lower urinary tract reconstruction, gastric segment, 630
Paget's disease, extramammary, eccrine sweat gland
Lymph node
carcinoma of scrotum, 789
dissection
Paraphimosis, reduction, with hyaluronidase (letter), 160
pelvic, laparoscopic, natural history of D1 (T1-3, N1-3,
Pediatric urology
MO) prostate cancer, 391
bilateral renal vein thrombosis in newborn, 128
retroperitoneal, testis cancer, post-chemotherapy, 957
bladder neck obstruction, rabbit neonatal, captopril
prostate cancer micrometastases (letter), 826
inhibition, 465
Lymphedema, genital, chronic, skin graft reconstruction,
botryoid rhabdomyosarcoma, bladder, 604
423
bowel segment use for lower urinary tract reconstruction,
long-term nutritional consequences, 967
circumcision in infancy (letter), 161, 315
Magnetic resonance imaging, ureteropelvic junction cystic renal disease and tuberous sclerosis in infants
obstructed kidney, 601 (letter), 485
Male infected obstructive ureterocele, 972
lower urinary tract symptoms inflammatory (pseudosarcomatous) myofibroblastic
correlation of presumed circle area ratio with tumor of bladder, 285
infravesical obstruction, 548 intrascrotal hemangioendothelioma in infancy, 456
doxazosin, 229 prepubertal varicocele, 774
younger, urinary symptomatology, 700 prolonged penile erection in newborn, 796
Managed care organizations, approaches to prostate cancer, pyeloplasty, 963
79 renal artery thrombosis in newborn infant, 282
Mesothelioma, pelvic, benign, 780 renal transplantation in children following augmentation
Metabolic complications secondary to obstruction of Kock ureterocystoplasty, 260
pouch afferent limb, 289 scrotal swelling, torsion of indirect hernia sac as cause of,
Microsurgery, simultaneous vasal reconstruction and 432
varicocele ligation, 438 testicular descent and ascent (letter), 826
Micturition, central neural control, 6A-36 ureteropelvic junction obstruction, transforming growth
Monoclonal antibodies factor-beta 1 urine levels, 769
anti-prostate-specific antigen, cross-reactivity with human Pelvic floor electrical stimulation, urge and mixed urinary
glandular kallikrein, 567 incontinence, women, 934
PRO:4-216, human prostate cancer nuclear matrix Pelvic mesothelioma, benign, 780
proteins, immunohistochemical characterization, 800 Penectomy, partial, penile carcinoma, quality of life, 593
MUSE therapy, alprostadil, 809 Penile cancer, partial penectomy, quality of life, 593
Myofibroblastic (pseudosarcomatous) tumor of bladder, Penile injector, no-needle, 994
inflammatory, 285 Penile prosthesis, simultaneous placement with radical
prostatectomy, immediate sexual rehabilitation by,
395,
Penis, calciphylaxis, 622
Neodymium:yttrium-aluminum-garnet laser prostatectomy, Penoscrotal transposition, modified pudendal-thigh flap, 597
prospective multicenter Prolase II clinical trial of, 63 Pentosan polysulfate, interstitial cystitis, 39
Nephrectomy, metastatic renal cell carcinoma, 673 Peripheral nerve sheath tumor, malignant, development,
Nephron-sparing surgery, renal allograft, 132 following treatment for testicular seminoma, 292
Neurologic control, bladder overactivity and incontinence, Peritoneal carcinomatosis with urachal signet cell
6A-36, 6A-57 adenocarcinoma, 446
Nitric oxide synthase, advanced glycation end products, Peyronie’s disease, immunologic findings, 764
penis, diabetes, 1016 Photodynamic therapy, recurrent superficial transitional cell
Nitrite, urinary, acidification, nitric oxide release and carcinoma of bladder, 199
bacterial growth, 189 Polymerase chain reaction. See also Reverse-transcriptase
Nutrition polymerase chain reaction
bowel segment use for lower urinary tract reconstruction, human papillomavirus detection prostate tissue primer set
pediatric, long-term, 967 utilized dependence, 150
prostate cancer, 840 Polyp, fibroepithelial, ureter, 280
1028L UROLOGY 50 (6), 1997
Polysaccharides, semisynthetic sulfated, postnatal Prostate cancer screening, African-American participation in
application in treatment of urolithiasis, 173 (letter), 483
Polyurethane bag, prevention of warm ischemia during renal Prostate cancer treatment
transplantation, 436 bicalutamide compared with flutamide, 330
Posterior lumbar approach, retroperitoneoscopic biological response modifiers, intralesional
adrenalectomy, 19 administration, 495
Primer set, human papillomavirus detection by polymerase c-myc antisense oligonucleotide, 1007
chain reaction, benign and malignant prostate tissue conformal external beam treatment of, 87
dependence, 150 cryotherapy, prostatic urethra stone formation, 615
Progelatinase A mRNA expression in cell lines derived from deferred, of clinically localized low-grade, 722
tumors in patients with metastatic renal cell DHEA for advanced, 784
carcinoma, correlation with survival, 295 erectile dysfunction, patient attitudes, 704
Prostate flutamide plus castration, in previously untreated (letter),
blastomycosis, 980 479
electrosurgical treatments of, energy utilization patterns, lymph node positive adenocarcinoma, radical
pilot study of, 138 prostatectomy, early adjuvant hormonal therapy, 833
transurethral needle ablation of (editorial), 167 oral estramustine and oral etoposide in hormone
Prostate biopsy, repeat, prostate-specific antigen, 66 refractory, 401, 754
Prostate cancer quality of life measurement, 920
adenocarcinoma. See Adenocarcinoma surgery or radiotherapy (letter), 479
allelic loss of 8p sequences, 643 transperineal interstitial radiofrequency ablation, 986
androgen-independent, prostate-specific antigen Prostate cells
transcripts in peripheral blood, 100
circulating, detection of, by reverse-transcriptase-polymer
approaches to by managed care organizations, 79
chain reaction of human glandular kallikrein and
biological behavior, color Doppler imaging, 906
prostate-specific antigen, 184
clinically aggressive, identification of transcript up-
epithelial, citrate metabolism, 3
regulation in, 302
Prostate imaging, in nonpalpable carcinoma of prostate, 385
clinically localized
Prostate-specific antigen
hazard rates for progression after radical prostatectomy,
density, role in predicting outcome for clinically localized
93
prostate cancer, re-examining of, 73
prostate-specific antigen in predicting outcome, re-
detection of circulating prostate cells, 184
examining, 73
free, finasteride, terazosin, watchful waiting, 901
D1 (T1-3, N1-3, MO), natural history of, effect of
and indices, determining need for repeat prostate biopsy,
laparoscopic pelvic lymph node dissection on, 391
66
fibroblast growth factor in adipose tissue and, 472
molecular forms, early detection and staging of prostate
nonpalpable, prostate imaging in, 385
cancer, 715
nuclear matrix proteins, monoclonal antibody PRO:4-216
precursor forms, pPSA, free PSA, prostate cancer serum,
preliminary immunohistochemical characterization,
710
800
PSAdynia, case history and taxonomy, 831
nutrition, 840
serum levels, benign prostatic hyperplasia, terazosin
organ-confined, anatomic site-specific positive margins,
effects, 556
radical prostatectomy outcome, 733
serum total and free, ejaculation effects on, 239
perspectives, comparison, 366
usefulness and as marker for prostate cancer, biological
predicting probability (letter), 655
variability of, effect of finasteride, 13
sons of men with, attitudes regarding inheritance,
Prostate-specific antigen assay, chemiluminescent, recurrent
screening, and genetic testing, 360
stage D1, delayed androgen deprivation (editorial), 838 prostate cancer detection, 573
stage D1 (T1-3, N1-3, MO), comparison of conservative Prostate-specific antigen positive circulating cells, detected
treatment versus radical prostatectomy, 251 by reverse transcriptase-polymerase chain reaction,
substages for metastatic (letter), 1027 prostatic micrometastases presence and, 245
Prostate cancer, metastasis, of hormone-refractory, painful Prostate-specific antigen transcripts, in peripheral blood
bone, strontium-89 and/or external radiotherapy, of patients with metastatic androgen-independent
costs, 747 prostatic carcinoma, prognostic significance of,
Prostate cancer detection 100
molecular forms of prostate-specific antigen and human Prostatectomy, laser. See Laser Prostatectomy
kallikrein 2, 715 Prostatectomy, radical
sextant protocol for ultrasound-guided core biopsy compared with radiotherapy (letter), 479
underestimation, 562 early adjuvant hormonal therapy, lymph node positive
Prostate cancer micrometastases, lymph nodes (letter), 826 adenocarcinoma of prostate (editorial), 833
Prostate cancer prognosis, DNA cytometric proliferation hazard rates for clinically localized prostate cancer
improvement in accuracy of DNA ploidy index as progression, 93
tool in, 379 laparoscopic, 854
Prostate cancer recurrence (letter), 316
early detection, chemiluminescent prostate-specific outcome, anatomic site-specific positive margins, organ-
antigen assay, 573 confined prostate cancer, 733
salvage cystoprostatectomy, orthotopic urinary diversion, prediction of extracapsular extension, systematic sextant
580 biopsies, 373
Prostate cancer risk, prediction, decision-making tool, 665 quality of life and sexuality, erectile aids and, 740
UROLOGY 50 (6), 1997 1028M
simultaneous placement of penile prosthesis with, metastatic
immediate sexual rehabilitation by, 395 nephrectomy and vena caval thrombectomy, 673
stage D1 prostate cancer, comparison with conservative progelatinase A mRNA expression in cell lines derived
treatment, 251 from, correlation with survival, 295
Prostatectomy, radical retropubic p53 and HER-2 alterations, 636
collagen mass in prostatic bed, 121 primary thyroidlike carcinoma (letter), 485
extraperitoneal endoscopic, 849 Renal colic, factitious, 858
preoperative recombinant human erythropoietin injection Renal failure, anuric, bilateral renal hematoma, 606
versus preoperative autologous blood donation, 727 Renal mass
Prostatic bed, collagen mass in, after radical retropubic reduced, lovastatin microcirculatory effects, 812
prostatectomy, 121 small, solid, fine needle aspiration of, prospective
Prostatic hyperplasia, benign evaluation of, accuracy and morbidity, 25
prostate-specific antigen serum levels, terazosin effects, Renal transplant recipients, bladder cancer, 525
556 Renal transplantation
in Sweden 1997 to 1994, changing patterns of treatment in children following augmentation ureterocystoplasty,
and cost, 214 260
transurethral microwave thermotherapy (editorial), 163 genitourinary malignancies and, 132
transurethral needle ablation, 167 nephrogenic adenoma of bladder, 690
transurethral vaporization of prostate, 235 warm ischemia, prevention with polyurethane bag, 436
Prostatic intraepithelial neoplasia Renal tubular acidosis, 279
allelic loss of 8p sequences, 643 Reverse transcriptase-polymerase chain reaction
transurethral resection specimens, clinical significance, human glandular kallikrein, circulating prostate cells
355 detection, 184
Prostatic urethral calculi, cryotherapy for prostate cancer, positive prostate-specific antigen circulating cells
615 detection, prostatic micrometastases, 245
Prostatitis Rhabdomyosarcoma
autoimmune, T cell reactivity with normal prostatic botryoid, bladder, 604
proteins, 893 paratesticular, inferior vena cava involvement, 978
diagnostic and treatment practices, questionnaire survey
of urologists and primary care physicians, 543
Protease inhibitor. See Indinavir sulfate
Scrotal swelling, children, torsion of indirect hernia sac, 432
Protein, prostatic, normal, T cell reactivity with,
Scrotum carcinoma, eccrine sweat gland, extramammary
autoimmune prostatitis, 893
Paget’s disease, 789
PSAdynia, case history and taxonomy, 831
Semen, cryopreserved, quality, cancer patient, lipid
Pseudodiverticulosis, ureteral, retrograde urogram for
peroxidation, 414
(letter), 316
Seminal vesicle aspiration, Turner biopsy needle, 277
Pudendal-thigh flap, modified, penoscrotal transposition,
Sexuality, radical prostatectomy, erectile aids, 740
597
Signet cell adenocarcinoma, urachal, peritoneal
Pyelocutaneous diversion, separated, after bilateral
carcinomatosis, 446
ureterectomy and radical cystectomy for transitional
Skin flap
cell carcinoma, 449
hypospadias repair
Pyelonephritis, xanthogranulomatous, nephrobronchial and
de-epithelialized, local, tubularization of incised
nephrocolonic fistula complicating, 443
urethral plate, 110
Pyeloplasty, pediatric, age and surgical technique, 963
sutureless, closure, dermal laser soldering, 263
Pyeloureteritis, cystic, radiologic aspects and differential
modified pudendal-thigh, penoscrotal transposition, 597
diagnosis, 31
Skin graft, chronic genital lymphedema reconstruction, 423
Sling. See Vaginal wall sling
Sperm, concentration, lipid peroxidation, 409
Quality of life Sphincter, urinary. See Urinary sphincter
overactive bladder, 6A-18 Sphincter-ureterovesical reflex, 949
partial penectomy for penile carcinoma, 593 Spinal cord injury, in male patients, urinary catheter and,
prostate cancer treatment, 920 urologic complications, 418
radical prostatectomy, erectile aids, 740 Stent
Quasi-IPSS index, calculation of (letter), 483 ureteral
combined percutaneous antegrade and cystoscopic
retrograde placement, ureteral discontinuity, 113
Radiofrequency ablation, transperineal interstitial, prostate migrated, balloon-wire retrieval (letter), 160
cancer, 986 urethral, UroLume double, treatment of complex urethral
Radiotherapy, prostate cancer stricture, 459
compared with radical prostatectomy (letter), 479 Sterilization, liquid, versus high level disinfection, in
conformal external beam, 87 urologic office, 337
external, hormone-refractory, bone metastasis, 747 Stool, guaiac conversion, following extracorporeal shock
Renal artery thrombosis, newborn, 282 wave lithotripsy, 192
Renal biopsy, retroperitoneoscopic, in extremely obese Storage solutions, bladder tissue preservation, 142
patients, 195 Stricture, urethral. See Urethral stricture
Renal calculi, staghorn, spiral computed tomography, 519 Strontium-89, hormone-refractory prostate cancer bone
Renal cell carcinoma metastasis, 747
collecting duct, low-grade, 673 Sweat gland, eccrine, carcinoma, scrotum, extramammary
5-fluorouracil and alfa-2b interferon, 863 Paget’s disease, 789
1028N UROLOGY 50 (6), 1997